CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 166 enrolled
Drug / intervention
Dexcom G6 Continuous Glucose Monitoring System (Dexcom Inc., San Diego, USA) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05803473
NCT05803473N/ACompleted

In-hospital Diabetes Management by a Diabetes Team and Continuous Glucose Monitoring or Point of Care Glucose Testing (DIATEC): a Randomised Trial

Peter Kristensen·interventional·Posted Apr 7, 2023·Updated Feb 26, 2025

In Brief

A clinical study evaluating Dexcom G6 Continuous Glucose Monitoring System (Dexcom Inc., San Diego, USA) and FreeStyle Precision Pro Glucometer for glucose POC testing for Diabetes Mellitus, Type 2. Completed, enrolled 166 participants across 2 sites.

Detailed Summary

This trial investigates the effects of continuous glucose monitoring (CGM) and an in-hospital diabetes team on in-hospital glycemic and clinical outcomes in patients with type 2 diabetes compared to standard glucose point-of-care (POC) testing and an in-hospital diabetes team.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesDenmark
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedApr 7, 2023
Enrollment StartApr 11, 2023
Primary CompletionMar 29, 2024
Study CompletionJul 29, 2024
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 3.2 years ago

Interventions

Dexcom G6 Continuous Glucose Monitoring System (Dexcom Inc., San Diego, USA)device

For CGM-arm subjects, glucose data are obtained by the CGM Dexcom G6 which via an iPhone SE 3 transmits data to the in-hospital diabetes team stations to be displayed on an iPad 9 10.2".

FreeStyle Precision Pro Glucometer for glucose POC testingdevice

For the POC-arm subjects, glucose assessment is done by standard ward glucometer.